Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.40 Billion ≈ $350.75 Million USD) by net assets (CN¥62.49 Billion ≈ $9.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Fosun Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Fosun Pharmaceutical Group Co L balance sheet liabilities for a breakdown of total debt and financial obligations.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beacon Roofing Supply Inc
NASDAQ:BECN
-0.070x
One 97 Communications Limited
NSE:PAYTM
0.051x
Nemetschek AG O.N.
XETRA:NEM
0.102x
TURK HA.YO.UNS.ADR 10 TN1
F:TU5A
N/A
Hoshine Silicon Ind Co Ltd
SHG:603260
0.006x
Chang Hwa Commercial Bank Ltd
TW:2801
-0.061x
Tripod Technology Corp
TW:3044
0.058x
Indutrade AB
ST:INDT
0.093x

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600196 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥62.49 Billion
≈ $9.14 Billion
CN¥6.01 Billion
≈ $878.76 Million
0.096x +28.64%
2024-12-31 CN¥59.93 Billion
≈ $8.77 Billion
CN¥4.48 Billion
≈ $655.12 Million
0.075x -3.07%
2023-12-31 CN¥56.62 Billion
≈ $8.28 Billion
CN¥4.36 Billion
≈ $638.48 Million
0.077x -1.13%
2022-12-31 CN¥54.11 Billion
≈ $7.92 Billion
CN¥4.22 Billion
≈ $617.16 Million
0.078x -4.51%
2021-12-31 CN¥48.38 Billion
≈ $7.08 Billion
CN¥3.95 Billion
≈ $577.83 Million
0.082x +45.50%
2020-12-31 CN¥45.98 Billion
≈ $6.73 Billion
CN¥2.58 Billion
≈ $377.50 Million
0.056x -31.75%
2019-12-31 CN¥39.20 Billion
≈ $5.74 Billion
CN¥3.22 Billion
≈ $471.54 Million
0.082x -6.40%
2018-12-31 CN¥33.59 Billion
≈ $4.92 Billion
CN¥2.95 Billion
≈ $431.69 Million
0.088x +1.23%
2017-12-31 CN¥29.74 Billion
≈ $4.35 Billion
CN¥2.58 Billion
≈ $377.57 Million
0.087x +3.82%
2016-12-31 CN¥25.25 Billion
≈ $3.69 Billion
CN¥2.11 Billion
≈ $308.77 Million
0.084x +6.55%
2015-12-31 CN¥20.67 Billion
≈ $3.02 Billion
CN¥1.62 Billion
≈ $237.21 Million
0.078x +24.82%
2014-12-31 CN¥19.10 Billion
≈ $2.80 Billion
CN¥1.20 Billion
≈ $175.63 Million
0.063x +9.71%
2013-12-31 CN¥17.66 Billion
≈ $2.58 Billion
CN¥1.01 Billion
≈ $148.03 Million
0.057x +31.70%
2012-12-31 CN¥15.30 Billion
≈ $2.24 Billion
CN¥665.52 Million
≈ $97.39 Million
0.043x +56.15%
2011-12-31 CN¥11.37 Billion
≈ $1.66 Billion
CN¥316.65 Million
≈ $46.34 Million
0.028x +28.63%
2010-12-31 CN¥9.39 Billion
≈ $1.37 Billion
CN¥203.36 Million
≈ $29.76 Million
0.022x -42.52%
2009-12-31 CN¥6.95 Billion
≈ $1.02 Billion
CN¥261.87 Million
≈ $38.32 Million
0.038x -28.14%
2008-12-31 CN¥4.45 Billion
≈ $650.58 Million
CN¥233.04 Million
≈ $34.10 Million
0.052x +72.08%
2007-12-31 CN¥4.32 Billion
≈ $631.62 Million
CN¥131.48 Million
≈ $19.24 Million
0.030x -39.90%
2006-12-31 CN¥3.65 Billion
≈ $533.90 Million
CN¥184.91 Million
≈ $27.06 Million
0.051x -22.64%
2005-12-31 CN¥2.88 Billion
≈ $420.71 Million
CN¥188.35 Million
≈ $27.56 Million
0.066x -10.12%
2004-12-31 CN¥2.81 Billion
≈ $411.75 Million
CN¥205.10 Million
≈ $30.01 Million
0.073x -2.08%
2003-12-31 CN¥2.02 Billion
≈ $295.14 Million
CN¥150.14 Million
≈ $21.97 Million
0.074x +21.56%
2002-12-31 CN¥1.67 Billion
≈ $244.87 Million
CN¥102.47 Million
≈ $15.00 Million
0.061x +18.84%
2001-12-31 CN¥1.32 Billion
≈ $193.54 Million
CN¥68.15 Million
≈ $9.97 Million
0.052x -54.64%
2000-12-31 CN¥1.22 Billion
≈ $178.30 Million
CN¥138.43 Million
≈ $20.26 Million
0.114x +95.42%
1999-12-31 CN¥657.08 Million
≈ $96.15 Million
CN¥38.20 Million
≈ $5.59 Million
0.058x -53.64%
1998-12-31 CN¥530.77 Million
≈ $77.67 Million
CN¥66.55 Million
≈ $9.74 Million
0.125x --

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic
Market Cap
$7.72 Billion
CN¥52.73 Billion CNY
Market Cap Rank
#2680 Global
#336 in China
Share Price
CN¥24.89
Change (1 day)
-1.54%
52-Week Range
CN¥23.51 - CN¥32.15
All Time High
CN¥85.06
About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumor… Read more